Matinas BioPharma Holdings, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (40)

Latest Posts

About This Stock More About This Stock
E Matinas Biopharma Is Highly Undervalued
Article By: Terry Chrisomalis
Monday, September 9, 2019 7:13 AM EDT
With cash concerns put to rest, a solid lead product MAT9001, and a unique lipid nano-crystal delivery technology, I believe Matinas Biopharma is highly undervalued.
In this article: MTNB Also: LGND, XOMA, AMRN, ABUS
Read
Matinas Well Positioned For June Data Read Outs
Article By: Jason Napodano
Tuesday, May 16, 2017 2:50 PM EDT
Matinas BioPharma Holdings, Inc. reported financial results for the first quarter ending March 31, 2017. The company also provided an update on anti-infective drug candidates, MAT2203 and MAT2501.
In this article: MTNB Also: MRK, ABT, PFE
Read
MAT2501 Phase 1 Data Look Good, Shares Look Attractive
Article By: Jason Napodano
Wednesday, March 29, 2017 10:09 AM EDT
Matinas Biopharma's stock is cheap and I can easily see Matinas getting taken out at much higher levels - like most anti-infectant companies do - perhaps after the pipeline matures a bit.
In this article: MTNB
Read
Matinas Expands Pipeline, Moves MAT2501 Into Phase 1
Article By: Jason Napodano
Monday, December 12, 2016 1:07 PM EDT
Matinas BioPharma is vastly undervalued at today's level of only $85 million. My valuation for the company's product MAT2203 is $400 million.
In this article: MTNB
Read
Matinas Initiates Important Phase 2 Study With MAT2203
Article By: Jason Napodano
Monday, November 21, 2016 1:22 PM EDT
Matinas BioPharma Holdings, Inc. announced the commencement of dosing in a Phase 2 clinical study examining MAT2203 in patients with vulvovaginal candidiasis (VVC).
In this article: MTNB
Read

PARTNER HEADLINES

Latest Tweets for $MTNB

No tweets yet!

$MTNB

Matinas Biopharma Is Highly Undervalued
Dick Kaplan 9/10/2019 12:31:04 AM

I agree that $MTNB is undervalued. There is a good buying opportunity here.

Matinas Biopharma Is Highly Undervalued
Bill Johnson 9/9/2019 5:47:21 PM

What's with your dislike of $MTNB? I found the article to be quite impressive.

Matinas Biopharma Is Highly Undervalued
Beating Buffett 9/9/2019 5:40:31 PM

$MTNB sounds like they have a real advantage over the competition.

1 to 3 of 3 comments